StockData
ResMed Inc logo

ResMed Inc

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3011% below fair value
$242.61+4.76 (+2.00%)

Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%

ResMed Global Devices by Year

Global Devices — Share of Trailing 12-Month Consolidated Revenue (%) (%)

Periods

ResMed Global Devices: 51.0% in FY2026, down 1.0 pts from a year earlier.

Latest, FY2026
51.0%
Period ended Jun 30, 2026 (CY2026)
Change on a year earlier
-1.0 pts
52.0% in FY2025
History
6 years
Since FY2021
Sources
6
Documents cited below

Where the FY2026 figure comes from

“pdates Performance Resmed | The global leader in connected and digital health Corporate Highlights TTM Financial Highlights Headquarters San Diego, CA Total HL revenue ~$5.7B 12%3 12%3 Founded 1989 CC Revenue YoY 8% Revenue Revenue growth 37% by business 50% 30% by region Listed (NYSE, Non-GAAP FY26 FY26 58% 1995, RMD Operating 36% ASX) margin Countries 1% 140+ Non-GAAP EPS served 17% YoY growth ▪ Sleep Devices ▪ Americas ▪ Life Support Devices ▪”

Source: ResMed Q4 FY2026 Company Overview Presentation (2026-09-15) ↗

Reported in ResMed Quarterly Earnings Presentations (At-a-Glance Business Mix).

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGlobal Devices — Share of Trailing 12-Month Consolidated Revenue (%) (%)Year on yearSource
FY2026CY2026Jun 30, 202651.0%-1.0 ptsResMed Q4 FY2026 Company Overview Presentation (2026-09-15) ↗
FY2025CY2025Jun 30, 202552.0%0.0 ptsResMed Q4 FY2025 Corporate Overview One-Pager (2025-07-31) ↗
FY2024CY2024Jun 30, 202452.0%-2.0 ptsResMed Q4 FY2024 Corporate Overview One-Pager (2024-08-01) ↗
FY2023CY2023Jun 30, 202354.0%+2.0 ptsResMed Q4 FY2023 Corporate Overview One-Pager (2023-08-03) ↗
FY2022CY2022Jun 30, 202252.0%+2.0 ptsResMed Q4 FY2022 Corporate Overview One-Pager (2022-08-11) ↗
FY2021CY2021Jun 30, 202150.0%–ResMed Q4 FY2021 Corporate Overview One-Pager (2021-08-05) ↗

Cite this data

StockData. (2026). ResMed Global Devices (%), annual FY2021–FY2026 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/dev-global-mix-ltm

See every metric in the ResMed KPI table. Data updated Nov 8, 2026.

See a number that looks wrong?